The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Open accessAbstract
Accumulating evidence suggests that neurodegeneration induced by pathogenic proteins depends on contributions from surrounding glia. Here we demonstrate that NF-kappaB signaling in microglia is critically involved in neuronal death induced by amyloid-beta (Abeta) peptides, which are widely presumed to cause Alzheimer disease. Constitutive inhibition of NF-kappaB signaling in microglia by expression of the nondegradable IkappaBalpha superrepressor blocked neurotoxicity, indicating a pivotal role for microglial NF-kappaB signaling in mediating Abeta toxicity. Stimulation of microglia with Abeta increased acetylation of RelA/p65 at lysine 310, which regulates the NF-kappaB pathway. Overexpression of SIRT1 deacetylase and the addition of the SIRT1 agonist resveratrol markedly reduced NF-kappaB signaling stimulated by Abeta and had strong neuroprotective effects. Our results support a glial loop hypothesis by demonstrating a critical role for microglial NF-kappaB signaling in Abeta-dependent neurodegeneration. They also implicate SIRT1 in this pathway and highlight the therapeutic potential of resveratrol and other sirtuin-activating compounds in Alzheimer disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a recent study it was found that over expression of SIRT1 deacetylase and SIRT1 activation by resveratrol significantly protects against microglia-dependent amyloid-β toxicity by inhibiting NF-kB signaling199.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 5,882
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,690
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,992
Control of IκB-α Proteolysis by Site-Specific, Signal-Induced Phosphorylation
Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., & Siebenlist, U. (1995) · Science · doi:10.1126/science.7878466 · Cited by 1,434
Mammalian SIRT1 Represses Forkhead Transcription Factors
Motta, M. C., Divecha, N., Lemieux, M. E., Kamel, C., Chen, D., Gu, W. J., Bultsma, Y., McBurney, M. W., & Guarente, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00126-6 · Cited by 1,366
Flagged first, then by citations
1 of the 54 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Walker, 2002, Curr. Opin. Investig. Drugs, 3, 782
- Chen, 2005, Mol. Cell. Biol.
Cited by
Sorted by citations
Items 201–300 of 743
Li, B., Liu, J., Gu, G., Han, X., Zhang, Q., & Zhang, W. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15001 · Cited by 110
Age-associated decrease of SIRT1 expression in rat hippocampus
Quintas, A., de Solís, A. J., Díez-Guerra, F. J., Carrascosa, J. M., & Bogónez, E. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2011.11.010 · Cited by 110
Microglia and inflammation: conspiracy, controversy or control?
Fernandes, A., Miller-Fleming, L., & Pais, T. F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1670-8 · Cited by 103
ADDLs and the signaling web that leads to Alzheimer’s disease
Krafft, G. A., & Klein, W. L. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.012 · Cited by 113
Sirtuins, resveratrol and the intertwining cellular pathways connecting them
Ungurianu, A., Zanfirescu, A., & Margina, D. M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101936 · Cited by 114
Cunha-Santos, J., Duarte-Neves, J., Carmona, V., Guarente, L., Pereira de Almeida, L., & Cavadas, C. (2016) · Nature Communications · doi:10.1038/ncomms11445 · Cited by 109
Sirtuins in Neuroendocrine Regulation and Neurological Diseases
Fujita, Y., & Yamashita, T. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00778 · Cited by 110
Icariin enhances neuronal survival after oxygen and glucose deprivation by increasing SIRT1
Wang, L., Zhang, L., Chen, Z., Wu, J., Zhang, X., & Xu, Y. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.033 · Cited by 108
Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
Wang, Q., Yao, H., Liu, W., Ya, B., Cheng, H., Xing, Z., & Wu, Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.772717 · Cited by 111
Design and synthesis of compounds that extend yeast replicative lifespan
Yang, H., Baur, J. A., Chen, A. Y., Miller, C. M., & Sinclair, D. A. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00259.x · Cited by 108
Kaur, U., Banerjee, P., Bir, A., Sinha, M. S., Biswas, A., & Chakrabarti, S. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150114160543 · Cited by 108
Role of dietary fatty acids in microglial polarization in Alzheimer’s disease
Desale, S. E., & Chinnathambi, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01742-3 · Cited by 112
Evaluation of potential pro‐survival pathways regulated by melatonin in a murine senescence model
Cuesta, J., Tajes, M., Jiménez, A., Coto‐Montes, A. M., Camins, A., & Pallàs, M. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00626.x · Cited by 104
Microglial Activation in Alzheimers Disease
Schlachetzki, J. C. M., & Hüll, M. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147179 · Cited by 105
Cheng, Y., Takeuchi, H., Sonobe, Y., Jin, S., Wang, Y., Horiuchi, H., Parajuli, B., Kawanokuchi, J., Mizuno, T., & Suzumura, A. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.02.001 · Cited by 102
Breitenstein, A., Stein, S., Holy, E. W., Camici, G. G., Lohmann, C., Akhmedov, A., Spescha, R. D., Elliott, P. J., Westphal, C. H., Matter, C. M., et al. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq339 · Cited by 106
Emerging roles of SIRT1 activator, SRT2104, in disease treatment
Chang, N., Li, J., Lin, S., Zhang, J., Zeng, W.-Q., Ma, G., & Wang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-55923-8 · Cited by 107
Li, D., Liu, N., Zhao, H., Zhang, X., Kawano, H., Liu, L., Zhao, L., & Li, H.-P. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0841-6 · Cited by 102
Tajes, M., Gutierrez‐Cuesta, J., Ortuño‐Sahagún, D., Camins, A., & Pallàs, M. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00706.x · Cited by 100
Velagapudi, R., El‐Bakoush, A., Lepiarz‐Raba, I., Ogunrinade, F., & Olajide, O. A. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3064-3 · Cited by 99
Reversal of aging by NFκB blockade
Adler, A. S., Kawahara, T. L. A., Segal, E., & Chang, H. Y. (2008) · Cell Cycle · doi:10.4161/cc.7.5.5490 · Cited by 103
Molecular Bases of Caloric Restriction Regulation of Neuronal Synaptic Plasticity
Fontán‐Lozano, Á., López‐Lluch, G., Delgado-Garcia, J. M., Navas, P., & Carrión, Á. M. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8040-1 · Cited by 104
Gao, B., Kong, Q., Kemp, K., Zhao, Y.-S., & Fang, D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118462109 · Cited by 98
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury
Lanzillotta, A., Sarnico, I., Ingrassia, R., Boroni, F., Branca, C., Benarese, M., Faraco, G., Blasi, F., Chiarugi, A., Spano, P., et al. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.76 · Cited by 98
Mokni, M., Limam, F., Elkahoui, S., Amri, M., & Aouani, E. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.10.015 · Cited by 97
Leonarduzzi, G., Sottero, B., & Poli, G. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.003 · Cited by 100
Chapter 24 NF‐KappaB Dimers in the Regulation of Neuronal Survival
Sarnico, I., Lanzillotta, A., Benarese, M., Alghisi, M., Baiguera, C., Battistin, L., Spano, P., & Pizzi, M. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)85024-1 · Cited by 97
Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases
Zhang, Y., Anoopkumar‐Dukie, S., Arora, D. S., & Davey, A. K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172847 · Cited by 95
Gabandé‐Rodríguez, E., Heras, M. M. G. D. L., & Mittelbrunn, M. (2019) · Cells · doi:10.3390/cells9010082 · Cited by 101
Inhibition of transcriptional activity of c-JUN by SIRT1
Gao, Z., & Ye, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.079 · Cited by 95
Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke
Shin, J. A., Lee, H.-A., Lim, Y.-K., Koh, Y., Choi, J. H., & Park, E. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.06.017 · Cited by 95
Kratz, E. M., Sołkiewicz, K., Kubis-Kubiak, A., & Piwowar, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020630 · Cited by 97
Alvira, D., Yeste‐Velasco, M., Folch, J., Verdaguer, E., Canudas, A. M., Pallàs, M., & Camins, A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.04.029 · Cited by 96
Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer’s Drug Discovery
Bu, X., Rao, P. P. N., & Wang, Y. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9301-4 · Cited by 97
Gilabert‐Oriol, R., Weng, A., von Mallinckrodt, B., Melzig, M. F., Fuchs, H., & Thakur, M. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140826153913 · Cited by 92
Sarubbo, F., Ramis, M. R., Kienzer, C., Aparicio, S., Esteban, S., Miralles, A., & Moranta, D. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9759-0 · Cited by 95
NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases
Lanzillotta, A., Porrini, V., Bellucci, A., Benarese, M., Branca, C., Parrella, E., Spano, P., & Pizzi, M. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00098 · Cited by 92
Specific Plasma Membrane Binding Sites for Polyphenols, Including Resveratrol, in the Rat Brain
Han, Y.-S., Bastianetto, S., Dumont, Y., & Quirion, R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102319 · Cited by 92
Activation of Nrf2 Pathway Contributes to Neuroprotection by the Dietary Flavonoid Tiliroside
Velagapudi, R., El-Bakoush, A., & Olajide, O. A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0975-2 · Cited by 91
Brain Activation of SIRT1: Role in Neuropathology
Paraíso, A. F., Mendes, K. L., & Santos, S. H. S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8459-x · Cited by 91
Research Progress on Alzheimer's Disease and Resveratrol
Yan, Y., Yang, H., Xie, Y., Ding, Y., Kong, D., & Yu, H. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03007-0 · Cited by 93
Intercellular interplay between Sirt1 signalling and cell metabolism in immune cell biology
Chen, X., Lu, Y., Zhang, Z., Wang, J., Yang, H., & Liu, G. (2015) · Immunology · doi:10.1111/imm.12473 · Cited by 91
Nopparat, C., Sinjanakhom, P., & Govitrapong, P. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12407 · Cited by 89
Pre-B cell colony enhancing factor (PBEF), a cytokine with multiple physiological functions
Sun, Z., Lei, H., & Zhang, Z. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.05.006 · Cited by 91
Build-UPS and break-downs: metabolism impacts on proteostasis and aging
Ottens, F., Franz, A., & Hoppe, T. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00682-y · Cited by 88
Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer’s Disease
Dhakal, S., Kushairi, N., Phan, C., Adhikari, B., Sabaratnam, V., & Macreadie, I. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205090 · Cited by 92
Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin‐induced mouse model of asthma
Ichikawa, T., Hayashi, R., Suzuki, K., Imanishi, S., Kambara, K., Okazawa, S., Inomata, M., YAMADA, T., YAMAZAKI, Y., Koshimizu, Y., et al. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02284.x · Cited by 88
Sirtuins: from metabolic regulation to brain aging
Duan, W. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00036 · Cited by 89
Sirt2 suppresses inflammatory responses in collagen-induced arthritis
Lin, J., Sun, B., Jiang, C., Hong, H., & Zheng, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.153 · Cited by 90
Rajendrasozhan, S., Yao, H., & Rahman, I. (2009) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550903049132 · Cited by 86
Cacabelos, R., Carril, J. C., Cacabelos, N., Kazantsev, A. G., Vostrov, A. A., Corzo, L., Cacabelos, P., & Goldgaber, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051249 · Cited by 87
Jiang, N., Lv, J., Wang, H., Huang, H. M., Wang, Q., Lü, C., Zeng, G., & Liu, X. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117669 · Cited by 86
Neuron-Glia Interactions as Therapeutic Targets in Neurodegeneration
Salmina, A. B. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0988 · Cited by 88
Xuan, A., Xue-bing, P., Wei, P., Ji, W., Zhang, W.-J., Liu, J., Hong, L.-P., Chen, W., & Long, D. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8751-4 · Cited by 91
Meng, X., Yang, J., Chen, G., Wang, L., Zhang, L., Wang, S., Li, J., & Wu, C. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.04.015 · Cited by 87
Sirtuin 1 and Alzheimer's disease: An up-to-date review
Rizzi, L., & Roriz‐Cruz, M. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.07.001 · Cited by 84
Dietary nutrition for neurological disease therapy: Current status and future directions
Mao, X., Yin, X., Guan, Q.-W., Xia, Q., Yang, N., Zhou, H., Liu, Z., & Jin, W. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107861 · Cited by 85
Oxygen metabolism abnormality and Alzheimer's disease: An update
Liu, G., Yang, C., Wang, X., Chen, X., Wang, Y., & Le, W. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102955 · Cited by 87
Cellular Links between Neuronal Activity and Energy Homeostasis
Shetty, P. K., Galeffi, F., & Turner, D. A. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00043 · Cited by 81
Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination
Caprariello, A. V., Mangla, S., Miller, R. H., & Selkirk, S. M. (2012) · Annals of Neurology · doi:10.1002/ana.23606 · Cited by 87
Valente, S., Mellini, P., Spallotta, F., Carafa, V., Nebbioso, A., Polletta, L., Carnevale, I., Saladini, S., Trisciuoglio, D., Gabellini, C., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01117 · Cited by 80
Epigenetic regulation of BACE1 in Alzheimer’s disease patients and in transgenic mice
Marques, S., Lemos, R., Ferreiro, E. B., Martins, M., de Mendonça, A., Santana, I. J., Outeiro, T. F., & Pereira, C. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.06.029 · Cited by 84
Roles of NAD / NADH and NADP+ / NADPH in Cell Death
Xia, W., Wang, Z., Wang, Q., Han, J., Zhao, C., Hong, Y., Zeng, L., Tang, L., & Ying, W. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787185832 · Cited by 82
Resveratrol Boosts Cognitive Function by Targeting SIRT1
Cao, W., Dou, Y., & Li, A. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2586-8 · Cited by 80
Ghosh, H. S., Spencer, J. V., Ng, B. G., McBurney, M. W., & Robbins, P. D. (2007) · Biochemical Journal · doi:10.1042/bj20070817 · Cited by 84
Selective targeting of microglia by quantum dots
Minami, S., Sun, B., Popat, K. C., Kauppinen, T. M., Pleiss, M., Zhou, Y., Ward, M. E., Floreancig, P. E., Mucke, L., Desai, T. A., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-22 · Cited by 79
Self-citationIKK2/NF‐κB signaling protects neurons after traumatic brain injury
Mettang, M., Reichel, S. N., Lattke, M., Palmer, A., Abaei, A., Rasche, V., Huber-Lang, M. S., Baumann, B., & Wirth, T. (2017) · The FASEB Journal · doi:10.1096/fj.201700826r · Cited by 78
Liu, L., Zhu, X., Zhao, T., Yu, Y., Xue, Y., & Zou, H. (2019) · Lara D. Veeken · doi:10.1093/rheumatology/kez165 · Cited by 79
Ma, C., & D’Mello, S. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.146860 · Cited by 83
Sirtuins in cognitive ageing and Alzheimer's disease
Braidy, N., Jayasena, T., Poljak, A., & Sachdev, P. S. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835112c1 · Cited by 81
Sellner, S., Paricio-Montesinos, R., Spieß, A., Masuch, A., Erny, D., Harsan, L. A., von Elverfeldt, D., Schwabenland, M., Biber, K. P. H., Staszewski, O., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0374-8 · Cited by 82
Histone Deacetylase Inhibitors and Neurodegenerative Disorders: Holding the Promise
Mai, A., Rotili, D., Valente, S., & Kazantsev, A. G. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649349 · Cited by 79
Sarubbo, F., Moranta, D., & Pani, G. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.05.011 · Cited by 77
Askanas, V., & Engel, W. K. (2011) · La Presse Médicale · doi:10.1016/j.lpm.2010.11.024 · Cited by 78
HIV TAT-mediated microglial senescence: Role of SIRT3-dependent mitochondrial oxidative stress
Thangaraj, A., Chivero, E. T., Tripathi, A., Singh, S., Niu, F., Guo, M.-L., Pillai, P., Periyasamy, P., & Buch, S. (2021) · Redox Biology · doi:10.1016/j.redox.2020.101843 · Cited by 76
Saito, M., Saito, M., & Das, B. C. (2019) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2019.01.007 · Cited by 75
Józkowiak, M., Hutchings, G., Jankowski, M., Kulcenty, K. I., Mozdziak, P. E., Kempisty, B., Spaczyński, R., & Piotrowska‐Kempisty, H. (2020) · Cells · doi:10.3390/cells9061418 · Cited by 74
Curcuminoids and resveratrol as anti-Alzheimer agents
Villaflores, O. B., Chen, Y., Chen, C., Yeh, J., & Wu, T. (2012) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2012.09.005 · Cited by 79
Review: NAD + : A modulator of immune functions
Grahnert, A., Grahnert, A., Klein, C., Schilling, E., Wehrhahn, J., & Hauschildt, S. (2010) · Innate Immunity · doi:10.1177/1753425910361989 · Cited by 78
SIRT3 protects cells from hypoxia via PGC-1α- and MnSOD-dependent pathways
Wang, Q., Li, L., Li, C. Y., Pei, Z., Zhou, M., & Li, N. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.045 · Cited by 77
Flavonoids-mediated SIRT1 signaling activation in hepatic disorders
Sayed, A. M. M., Hassanein, E. H. M., Salem, S. H., Hussein, O. E., & Mahmoud, A. M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118173 · Cited by 77
Hippocampal Neurogenesis in Alzheimer's Disease: Is There a Role for Dietary Modulation?
Maruszak, A., Pilarski, A. M., Murphy, T., Branch, N., & Thuret, S. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-131004 · Cited by 78
Can changes in histone acetylation contribute to memory formation?
López‐Atalaya, J. P., & Barco, Á. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.09.003 · Cited by 79
Li, M., Ji, J., Zheng, L.-J., Shen, J., Li, X., Zhang, Q., Bai, X., & Wang, Q. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.239449 · Cited by 74
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
Uddin, M. S., Kabir, M. T., Jalouli, M., Rahman, M. A., Jeandet, P., Behl, T., Alexiou, A. T., Albadrani, G. M., Abdel‐Daim, M. M., Perveen, A., et al. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210826130210 · Cited by 76
Antioxidant Properties of Resveratrol and its Protective Effects in Neurodegenerative Diseases
Gerszon, J., Rodacka, A., & Puchała, M. (2014) · Postepy Biologii Komorki · doi:10.2478/acb-2014-0006 · Cited by 71
TNF-α/NF-κB Signaling in the CNS: Possible Connection to EPHB2
Pozniak, P. D., White, M. K., & Khalili, K. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9517-x · Cited by 76
Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide
Song, S. B., Park, J., Chung, G. J., Lee, I. H., & Hwang, E. S. (2019) · Metabolomics · doi:10.1007/s11306-019-1604-4 · Cited by 73
Kaewmool, C., Kongtawelert, P., Phitak, T., Pothacharoen, P., & Udomruk, S. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577164 · Cited by 75
Chandramowlishwaran, P., Vijay, A., Abraham, D., Li, G., Mwangi, S. M., & Srinivasan, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614331 · Cited by 74
The role of sirtuins in Alzheimer's disease
Lalla, R., & Dönmez, G. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00016 · Cited by 71
Chaudhuri, A. D., Yelamanchili, S. V., Marcondes, M. C. G., & Fox, H. S. (2013) · The FASEB Journal · doi:10.1096/fj.13-232678 · Cited by 72
Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives
Lanzillotta, C., Domenico, F. D., Marzia Perluigi, A., & Butterfield, D. A. (2019) · CNS Drugs · doi:10.1007/s40263-019-00658-8 · Cited by 75
Zhao, H., Wang, S., Qian, L., Jin, J., Li, H., Xu, Y., & Zhu, X. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12043 · Cited by 71
The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration
Chen, D., Steele, A. D., Hütter, G., Bruno, J., Govindarajan, A., Easlon, E. J., Lin, S.-J., Aguzzi, A., Lindquist, S. L., & Guarente, L. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.08.050 · Cited by 74
Barroso, E., Eyre, E., Palomer, X., & Vázquez‐Carrera, M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.004 · Cited by 72
Srivastava, S., & Haigis, M. C. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072526 · Cited by 70
Echeverrı́a, V., Burgess, S., Gamble‐George, J., Zeitlin, R., Lin, X., Cao, C., & Arendash, G. W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.019 · Cited by 70
Silent information regulator, Sirtuin 1, and age‐related diseases
Zeng, L., Chen, R., Liang, F.-X., Tsuchiya, H., Murai, H., Nakahashi, T., Iwai, K., Takahashi, T., Kanda, T., & Morimoto, S. (2009) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2008.00504.x · Cited by 72
Pan, X., Chen, X., Zhu, Y., Chen, L., Zhang, J., Huang, T., Ye, Q., & Huang, H. (2009) · Glia · doi:10.1002/glia.20844 · Cited by 70
Self-citation
Metadata
- Authors
- Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Gan, Li
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 280
- Issue
- 48
- Pages
- 40364-40374
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2074916731
- Cited by
- 740
- References
- 54
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 35 · 2023: 36 · 2022: 22 · 2021: 39 · 2020: 49 · 2019: 30 · 2018: 46 · 2017: 40 · 2016: 26 · 2015: 35 · 2014: 35 · 2013: 48 · 2012: 43
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- University of California, San Francisco
- National Institute of Neurological Disorders and Stroke (NS43945, R01NS043945)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- SIRT1, microglia, amyloid-beta, NF-κB signaling, Alzheimer's disease, neurodegeneration, resveratrol, neuroprotection
- MeSH terms
- Resveratrol, Alzheimer Disease, Animals, Bromodeoxyuridine, Cells, Cultured, Genetic Vectors, Humans, Immunohistochemistry, Lysine, Microscopy, Fluorescence, Models, Biological, Models, Genetic, Neurons, Stilbenes, Signal Transduction, Lentivirus, Amyloid beta-Peptides, NF-kappa B, Rats, Sprague-Dawley, Microglia, Genes, Reporter, Reverse Transcriptase Polymerase Chain Reaction, Sirtuins, Green Fluorescent Proteins, Rats, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review